All anti-CD20 monoclonal antibodies have similar efficacy and risks: No-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

All anti-CD20 monoclonal antibodies have similar efficacy and risks: No

Published:2022-09-20 Issue:12 Volume:28 Page:1845-1846
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Sellebjerg Finn¹,Romme Christensen Jeppe²

Affiliation:

1. Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital – Rigshospitalet, Glostrup, Denmark/Department of Clinical Medicine, Institute of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

2. Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital – Rigshospitalet, Glostrup, Denmark

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/13524585221103729

Reference10 articles.

1. Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis

2. Targeting B cells in multiple sclerosis

3. Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties

4. Monitoring B-cell repopulation after depletion therapy in neurologic patients

5. Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP